Archives

by in
Entry Author Date Location
Indel Therapeutics Aims High With New Class of Antibiotics to Fight Hospital Infections 03/30/09 Seattle
Vioguard CEO Larry Ranta Takes Germ-Zapping Keyboard Into Growing Hospital Market 03/26/09 Seattle
Calixa Passes Key Safety Test in Clinical Trial of New Antibiotic 03/24/09 San Diego
Novophage Forming to Combat Antibiotic Resistance with Engineered Viruses 03/05/09 Boston
Teva Takes Aim at Cubist Pharma’s Key Antibiotic Business 02/10/09 Boston
Rib-X Raises $25M in Debt Financing, Reveals Final Results of Antibiotic Trial 01/26/09 Boston
Cepheid, Maker of Test to Spot MRSA Staph Infections, Builds Growing Presence in Washington 12/22/08 Seattle
Targanta Faces New Challenges to Raise Cash After FDA Shoots Down the Firm’s Antibiotic 12/10/08 Boston
Rib-X Reveals “Positive” Antibiotic Data 12/08/08 Boston
Simple DNA Test Spots Deadly MRSA Bacteria; Adnavance Aims To Take It Mainstream 11/10/08 San Diego
Isis Spinoff Ibis Biosciences, Looking at DNA of Infectious Bugs, Aims to Identify What They Are, Faster 10/27/08 San Diego
Targanta Releases Antibiotic Data 10/22/08 Boston
Trius Therapeutics Wins $28M Contract From NIH For Bioterror Antibiotics 10/22/08 San Diego
Trius Therapeutics, Developer of Antibiotic Against MRSA, Taking On Pfizer’s Zyvox 10/20/08 San Diego
Targanta Preps For FDA Advisory Panel on New Antibiotic 10/14/08 Boston
Targanta Aims to “Simplifi” Treatment of Deadly Bugs With Single-Shot Antibiotic 09/22/08 Boston
Targanta Antibiotic Shown Effective in Less-Frequent Dose 09/02/08 Boston
Navilyst Medical, Boston Scientific Spin-Off, Aiming to Tap Veins Without Causing Infections 08/05/08 Boston
Thermo Fisher MRSA Test Approved 04/04/08 Boston
Nomir to Microbes: We’re Out to Get You 11/01/07 Boston
Page 2 of 2 « previous page